Press Release
March 29, 2023

Kiro Raises €13.8 Million in Series A

The Paris Life Sciences team advised Kiro, a developer of a diagnosis platform designed to assist medical examinations, in its €13.8 million Series A.

This financing round was led by Sofinnova Partners and included Propulia, business angels and existing investors Bpifrance and Kurma Partners.

The proceeds will be used to further develop the platform and to expand commercial operations in Europe and prepare entry into the US market.

The Goodwin team was led by Anne-Charlotte Rivière and included Louis Taslé d’Héliand, Grégoire Mongis and Coralie Davis on corporate aspects and Marie Fillon and Louis de Chezelles on IP aspects.